the provision of Wegovy turned an issue in 2022 on account of the recognition of the drug taking the maker, Novo Nordisk, abruptly. Demand outstripped its manufacturing abilities. And people had been not able to find the medication. And knowledge revealed in 2024 on medications, which include semaglutide and tirzepatide, indicated that people with